Recovery of Systolic Dysfunction in Duchenne Muscular Dystrophy due to the Point Mutation c.4213C>T

Josef Finsterer,Claudia Stöllberger,Elke Holinski-Feder

Recovery of Systolic Dysfunction in Duchenne Muscular Dystrophy due to the Point Mutation c.4213C>T

2010

Josef Finsterer
Claudia Stöllberger
Elke Holinski-Feder

Objectives: So far, a beneficial effect of combined angiotensin-converting enzyme inhibitors (ACEI) and β-blocker therapy for systolic dysfunction in Duchenne muscular dystrophy (DM

Keywords:

Duchenne muscular dystrophy
Dystrophin
Cardiology
Internal medicine
Heart failure
Dilated cardiomyopathy
Diabetes mellitus
Muscular dystrophy
Point mutation
Medicine
Bisoprolol
Enalapril
Asymptomatic

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations